Johnson & Johnson reports promising early results for targeted bladder cancer therapy
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
One task, one interaction, one pair, experts advocate
The hospitals house over 25 super-speciality centres and Centres of Excellence in Cardiology, Neurology, Oncology, Paediatrics, Orthopaedics, ENT, Obstetrics and Gynaecology, General Surgery, Internal Medicine, Critical Care, and Chronic Disease Management
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
If approved, Ameluz would become the first and only photodynamic therapy (PDT) photosensitizer for sBCC in the US
HCG clinicians contributing to one of the largest bodies of oncology research from India
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
Subscribe To Our Newsletter & Stay Updated